A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members

References

• Blau E. B. Familial granulomatous arthritis, iritis and rash. J Pediatr 1985; 107: 689–93
   PubMed Web of Science ®Google Scholar
• Pastores G. M., Michels V. V., Stickler G. B., Su W. P., Nelson A. M., Bovenmyer D. A. Autosomal dominant granulomatous arthritis, uveitis, skin rash and synovial cysts. J Pediatr 1990; 117: 403–8
   Google Scholar
• Manouvrier‐Hanu S., Puech B., Piette F., Boute‐Benejean O., Desbonnet A., Duquesnoy B., et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Gen 1998 1998; 217–22
   Google Scholar
• Miceli‐Richard C., Lesage S., Rybojad M., Prieur A. M., Manouvrier‐Hanu S., Häfner R., et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29: 19–20
   PubMed Web of Science ®Google Scholar
• Wang X., Kuivaniemi H., Bonavita G., Mutkus L., Mau U., Blau E., et al. CARD15 mutations in familial granulomatosis syndrome. Arthritis Rheum 2002; 30: 41–5
   Google Scholar
• Priori R., Bombardieri M., Spinelli F. R., Merlin F., Miceli‐Richard C., La Cava M., et al. Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with a lifelong follow‐up. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 228–31
   PubMed Web of Science ®Google Scholar
• Rosé C. D., Doyle T. M., McIlvain‐Simpson G., Coffman J. E., Rosenbaum J. T., Davey M. P., et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005; 32: 373–5
   PubMed Web of Science ®Google Scholar
• Rosé C. D., Wouters C. H., Meiorin S., Doyle T. M., Davey M. P., Rosenbaum J. T., et al. Pediatric granulomatous arthritis: an international registry. Arthritis Rheum 2006; 54: 3337–44
   PubMed Web of Science ®Google Scholar
• Aróstegui J. I., Arnal C., Merino R., Modesto C., Antonia Carballo M., Moreno P., et al. NOD2 gene‐associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin‐1 blockade in a Spanish cohort. Arthritis Rheum 2007; 56: 3805–13
   PubMed Web of Science ®Google Scholar
• Milman N., Andersen C. B., Hansen A., van Overeem Hansen T., Nielsen F. C., Fledelius H., et al. Favourable effect of TNFα inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 2006; 114: 212–19
   Google Scholar
• Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata‐Hizume M., Nagai S., et al. Early‐onset sarcoidosis and CARD15 mutations with constitutive nuclear factor‐kappaB activation: common genetic etiology with Blau syndrome. Blood 2005; 105: 1195–7
   PubMed Web of Science ®Google Scholar
• van Duist M. M., Albrecht M., Podswiadek M., Giachino D., Lengauer T., Punzi L., et al. A new Card15 mutation in Blau syndrome. Eur J Hum Genet 2005; 13: 742–7
   PubMed Web of Science ®Google Scholar
• Becker M. L., Rosé C. D. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 2005; 7: 427–33
   PubMedGoogle Scholar
• Lesage S., Zouali H., Cezard J. P., Colombel J. F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–57
   PubMed Web of Science ®Google Scholar
• Schurmann M., Valentonyte R., Hampe J., Müller‐Quernheim J., Schwinger E., Schreiber S., et al. CARD15 gene mutations in sarcoidosis. Eur J Resp Dis 2003; 22: 748–54
   Google Scholar
• Milman N., Nielsen F. C., Hviid T. V. F., Hansen T. v. O. Blau syndrome‐associated mutations in exon 4 of the caspase activating recruitment domain 15 (CARD15) gene are not found in ethnic Danes with sarcoidosis. Clin Respir J 2007; 1: 74–9
   Google Scholar
• Andersen P. S., Jespersgaard C., Vuust J., Christiansen M. High‐throughput single strand conformation polymorphism mutation detection by automated capillary array electrophoresis: validation of the method. Hum Mutat 2003; 21: 116–22
   Google Scholar
• Rybicki B. A., Maliarik M. J., Bock C. H., Elston R. C., Baughman R. P., Kimani A. P., et al. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 203–8
   PubMed Web of Science ®Google Scholar
• Masel G., Halbert A. Blau syndrome presenting with ichthyosis. Australas J Dermatol 2005; 46: 29–32
   PubMedGoogle Scholar
• Hoffmann L., Milman N., Byg K‐E. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results in 48 children. Acta Pædiatr 2004; 93: 30–6
   PubMed Web of Science ®Google Scholar
• Ting S. S., Ziegler J., Fischer E. Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr 1998; 133: 450–2
   PubMedGoogle Scholar
• Becker M. L., Martin T. M., Doyle T. M., Rosé C. D. Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum 2007; 56: 1292–4
   Google Scholar
• North A. E., Fink C. W., Gibson W. M., Levinson J. E., Schuchter S. L., Howard W. K., et al. Sarcoid arthritis in children. Am J Med 1970; 48: 449–55
   Google Scholar
• Hetherington S. Sarcoidosis in young children. Am J Dis Child 1982; 136: 13–15
   PubMedGoogle Scholar
• Pattishall E. N., Kendig E. L. Sarcoidosis in children. Pediatr Pulmonol 1996; 22: 195–203
   Google Scholar
• King K., Sheikh M. F., Cuthbert A. P., Fisher S. A., Onnie C. M., Mirza M. M., et al. Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat 2006; 27: 44–54
   Google Scholar
• Carneiro L. A. M., Travassos L. H., Girardin S. E. Nod‐like receptors in innate immunity and inflammatory diseases. Ann Med 2007; 39: 581–93
   PubMed Web of Science ®Google Scholar
• Chamaillard M., Philpott S., Girardin S. F., Zouali H., Lesage S., Chareyre F., et al. Gene–environment interaction moduled by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100: 3455–60
   PubMed Web of Science ®Google Scholar
• Moller D. R. Treatment of sarcoidosis – from a basic science point of view. J Intern Med 2003; 253: 31–40
   PubMed Web of Science ®Google Scholar
• Fehrenbach H., Zissel G., Goldmann T., Tschernig T., Vollmer E., Pabst R., et al. Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis. Eur Resp J 2003; 21: 421–8
   PubMed Web of Science ®Google Scholar
• Doty J. D., Mazur J. E., Judson M. A. Treatment of sarcoidosis with infliximab. Chest 2005; 127: 1064–71
   PubMed Web of Science ®Google Scholar
• Wyser C. P., van Schlakwyk E. M., Alheit B., Bardin P. G., Joubert J. R., et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: a randomized controlled trial. Am J Respir Crit Care Med 1997; 156: 1571–6
   Web of Science ®Google Scholar